medline.ch Respirationstrakt Neoplasie

	A lncRNA and radiomics-based model for predicting the response of non-small cell lung cancer to chemo- and radio-therapy. Sci Rep Ye F, Yin Y, Wang J, Wang J, Yang J, Zhang J, Zhang Y, Qi J, Zhu Q, Zhang Y, Ji H, Hu Z, Hong B, Wang H. PMID: 41673451 [PubMed - as supplied by publisher]
	HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma. Sci Data Yan Z, Huang H, Guo Y, Shi J, Geng R, Zhang J, Chen Y, Nie Y. PMID: 41673396 [PubMed - as supplied by publisher]
	BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer. Sci Rep Liu M, Zhu S, Zheng Q, Ding D, Li S. PMID: 41673219 [PubMed - as supplied by publisher]
	LedX: A novel blood-based early lung cancer detection approach with exceptional accuracy and robustness. Chin Med J (Engl) Zhang D, Xu X, Ma C, Tang X, Su Z, Ji S, Chao Y, Zhang Y, Ding N, Xie K, Chen W, Wang H, Liu R, Hu J. PMID: 41672932 [PubMed - as supplied by publisher]
	Aptasensors for NNK biomarkers in smoking-induced lung cancer. Clin Chim Acta Alenezi BT, Jawaid T, Ur Rehman Z, Alzahrani AR, Hai A, Fatima W, Alam P, Khan A. PMID: 41672291 [PubMed - as supplied by publisher]
	The influence of exposure and observed mortality definitions when estimating lung cancer attributable mortality to secondhand smoke exposure. J Clin Epidemiol Guerra-Tort C, Rey-Brandariz J, Candal-Pedreira C, García G, de Luis Cid L, Pérez-Ríos M. PMID: 41672161 [PubMed - as supplied by publisher]
	Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer. Lung Cancer Akagi K, Taniguchi H, Fukuda M, Yamazaki T, Takao D, Tagawa R, Hayashi F, Ogata R, Ono S, Tomono H, Suyama T, Honda N, Umeyama Y, Dotsu Y, Matsuo M, Gyotoku H, Senju H, Takemoto S, Soda H, Mizowaki T, Ikeda T, Nagashima S, Tasaki Y, Nakamura D, Komiya K, Nakatomi K, Sasaki E, Hirakawa K, Toya R, Ashizawa K, Mukae H. PMID: 41671905 [PubMed - as supplied by publisher]
	Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK Biobank. EBioMedicine Gao R, Liao Y, Zheng Q, Xu Z, Zhao X, Guo Q, Wang Z, Duan J, Wan R, Xu J, Fei K, Sun B, Zhuang W, Bai H, Cheng Y, Zhong J, Wang J. PMID: 41671868 [PubMed - as supplied by publisher]
	Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis. Lung Cancer Zhou C, Tang KJ, Liu B, Kim SW, Kitazono S, Ono A, Thiagarajan M, Hung JY, Boyer M, Ç, Yao Y, Nagarkar R, Xie J, Bhattacharya A, Wortman-Vayn H, Baig M, Agrawal T, Lorenzini P, Lee SH, Cho BC. PMID: 41671628 [PubMed - as supplied by publisher]
	Incremental prognostic value of immune cell densities beyond clinical parameters in non-small cell lung cancer. Lung Cancer Nordling L, Backman M, Mezheyeuski A, Lindblad J, Sladoje N, Micke P. PMID: 41671623 [PubMed - as supplied by publisher]
	Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study. JMIR Cancer Iniesta-Chamorro JM, Sereno M, Garrido-Rubiales B, Villarino Sanz M, Espinosa-Salinas I, Falagán Martínez S, Rubio Romero G, Moreno-Rubio J, Tabarés B, Martín Y, Hernández de Córdoba I, Morales Parga M, Molinero N, Moreno-Arribas MV, Reglero Rada G, Ramírez de Molina A, Gómez EJ, Casado E. PMID: 41671557 [PubMed - indexed for MEDLINE]
	Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net Population. J Natl Compr Canc Netw Bhalla S, Hamann HA, Prasad T, Mullins MA, Malone ST, Rodriguez J, Gwin ME, Natchimuthu V, Nair RG, Ibekwe-Agunanna LN, Craddock Lee SJ, Johnson DH, Wahid U, Gao A, Zhang S, Gerber DE. PMID: 41671468 [PubMed - indexed for MEDLINE]
	NCCN GuidelinesÂ® Insights: Small Cell Lung Cancer, Version 2.2026. J Natl Compr Canc Netw Ganti AKP, Loo BW Jr, Badiyan S, Bassetti M, Bestvina C, Chiang A, Choudhury N, D'Avella CA, Daly M, Dowlati A, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Khalil M, Lee R, Malhotra J, Merritt RE, Mohindra N, Molina JR, Moran C, Mulvey C, Osmundson EC, Patel S, Patil T, Pokharel S, Puri S, Qin A, Sands J, Shields M, Tailor TD, Waqar SN, Cassara CJ, Ramakrishnan S. PMID: 41671459 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective Study. J Natl Compr Canc Netw Waliany S, Roy SG, Pecci F, Weber UM, Sun F, Arter Z, Lomibao M, Alessi JV, Nishino M, Luo F, Repetto M, Falcon C, Do A, Peterson J, Liang J, Liu A, Nagasaka M, Ricciuti B, Drilon A, Ou SI, Neal JW, Patil T, Awad M, Yeap BY, Digumarthy SR, Lin JJ. PMID: 41671458 [PubMed - indexed for MEDLINE]
	From Diagnosis, Therapy Decision-Making to Genetic Risk Assessment: The Impact of ctDNA Testing on Comprehensive Cancer Management-A Case Report. J Natl Compr Canc Netw Kanwar N, Seyi AB, Tan N, Rojas C, Ernani V, Rumilla KM, Borad MJ, Zheng G. PMID: 41671451 [PubMed - indexed for MEDLINE]
	Identifying regulatory driver motifs in non-small cell lung carcinoma via a systematic approach. PLoS One Kumar R, Massey S, Albogami S, Aloliqi AA, Asiri A, Aljohani MM, Aljohani HM, Kumar A, Dev K. PMID: 41671297 [PubMed - indexed for MEDLINE]
	Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study. Clin Cancer Res Chen M, Bulat I, Maglakelidze M, Li N, Chen Z, Kong W, Li Y, Fang J, Zhang J, Zhang J, Wang B, Ma J, Sun Y, Wang Q, Chen X, Liu X, Yu T, Hanley WD, Budha N, Li H, Lin X, Niu Z, Jamal L, Abdrashitov R, Wang M. PMID: 41671081 [PubMed - as supplied by publisher]
	Genomic alterations and their correlation with metabolic-related genes in lung cancer. Clin Transl Oncol Gaur G, Jha NK, Gambhir L, Acharya SV, Kumar D. PMID: 41670818 [PubMed - as supplied by publisher]
	Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy. Naunyn Schmiedebergs Arch Pharmacol Gumma L, Gumma B, Yarrabothula LP. PMID: 41670693 [PubMed - as supplied by publisher]
	T-Cell Immunity and Lung Cancer. Respirology Yamada K, Togashi Y. PMID: 41669970 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 157174

Seite 1 von 7859



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung